Corteva Sees $300M Of Gross Productivity Benefits Across 2027-2029; Corteva Sees More Than $200M Of Net Cost Improvement Across 2027-2029, After Inflation And Tariff Offsets; Residual Inflation And Tariff Impacts Will Be Concentrated Mostly In 2027; Says Its Seed-Treatment Portfolio Is Now About $500M, Vs. About $400M Before Separation

Corteva announced projected gross productivity benefits of $300 million from 2027 to 2029, alongside net cost improvements exceeding $200 million during the same period, after accounting for inflation and tariff offsets. The company noted that residual inflation and tariff impacts will primarily affect 2027. Additionally, Corteva's seed-treatment portfolio has grown to approximately $500 million, up from about $400 million prior to the company's separation.